ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 298

Factors Affecting Inpatient Mortality in Hospitalizations for Sepsis with Underlying Systemic Lupus Erythematosus: Data from the National Inpatient Sample 2010-2014

Karan Chugh1, Karan Jatwani2, Jasleen Kaur3 and Shraddha Jatwani4, 1Division of Pulmonary, Critical Care & Sleep, Wayne State University/Detroit Medical Center, Detroit, MI, 2Department of Internal Medicine, Mount Sinai West - St Luke’s Hospital, New York, NY, 3Department of Internal Medicine, Wayne State University/Detroit Medical Center, Detroit, MI, 4Department of Internal Medicine, Division of Rheumatology, Henry Ford Allegiance Health, Jackson, MI

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Morbidity and mortality and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Health Services Research Poster I – ACR/ARHP

Session Type: ACR/ARHP Combined Abstract Session

Session Time: 9:00AM-11:00AM

Background/Purpose:

Infections are associated with significant morbidity and mortality in systemic lupus erythematosus (SLE). Clinical outcomes of SLE patients hospitalized is variable due to variable demographic distribution. Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection with significant increase in inpatient mortality. Data describing clinical outcomes and factors associated with poor outcomes of patients with sepsis with SLE is limited in current literature. Our objective is to evaluate factors affecting mortality in patients with sepsis and underlying SLE.

Methods:

We used the National Inpatient Sample (NIS) available through Healthcare Cost and Utilization Project (HCUP) to estimate the number of hospitalizations for sepsis among adult patients with SLE in the US from 2010-2014. ICD-9 CM codes were used to identify the population. Logistic regression analysis was used to identify independent associations of in-hospital mortality. We described the associations as patient factors and hospital factors.

Results:

We identified 35475 hospitalizations for sepsis with secondary diagnosis of SLE using NIS database from 2010-2014. There were 3557 inpatient deaths during these hospitalizations. Mean age of patients admitted with sepsis and SLE was 54.145 years. Analysis of the population with inpatient mortality, suggested increased odds of mortality with age, location & size of hospital and number of associated comorbidities. Odds of mortality were noted to decrease with female sex and insurance status, as reported in Table 1.

Conclusion:

This study suggests increased risk of inpatient mortality in males, with increasing age and increase in number of comorbidties. Previous studies have shown similar results. Urban and large hospitals were found to be associated with higher mortality. This may represent higher likelihood of patients with comorbidities like SLE being referred or transferred to larger urban hospitals. Serious infections continue to be an important source of mortality in SLE. And factors affecting the mortality can guide us to implement guidelines for prevention and management of infections including but not limited to vaccinations, especially in high risk subgroup including males, older population with SLE and patients with multiple comorbidities.

Table 1: Factors associated with inpatient mortality in patients with sepsis and underlying SLE

Variable

Odds Ratio

P value

PATIENT FACTORS

Age

1.027

0.000

Sex

Male

Reference

Female

0.752

0.010

Race

White

Reference

Black

0.906

0.310

Hispanic

0.799

0.084

Asian or Pacific Islander

0.908

0.701

Native American

0.957

0.914

Other

0.912

0.736

Charlson Comorbidity Index

1

2

1.397

0.008

3

1.414

0.005

>=4

2.312

0.000

Insurance Status

Medicare

Reference

Medicaid

0.724

0.004

Private

0.596

0.000

Self-Pay

0.461

0.005

Median household income quartiles for patient’s ZIP Code (in dollars)

$1-38,999

Reference

$39000-47999

1.073

0.482

$48000-62999

0.921

0.451

>$63000

0.855

0.192

HOSPITAL FACTORS

Teaching Status of Hospital

Non-Teaching

Reference

Teaching

1.101

0.243

Hospital Location

Rural

Reference

Urban

1.488

0.012

Hospital Region

Northeast

Reference

Midwest

0.7956

0.104

South

1.072

0.557

West

0.876

0.309

Hospital Bed-size

Small

Reference

Medium

1.280

0.088

Large

1.362

0.019


Disclosure: K. Chugh, None; K. Jatwani, None; J. Kaur, None; S. Jatwani, None.

To cite this abstract in AMA style:

Chugh K, Jatwani K, Kaur J, Jatwani S. Factors Affecting Inpatient Mortality in Hospitalizations for Sepsis with Underlying Systemic Lupus Erythematosus: Data from the National Inpatient Sample 2010-2014 [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/factors-affecting-inpatient-mortality-in-hospitalizations-for-sepsis-with-underlying-systemic-lupus-erythematosus-data-from-the-national-inpatient-sample-2010-2014/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-affecting-inpatient-mortality-in-hospitalizations-for-sepsis-with-underlying-systemic-lupus-erythematosus-data-from-the-national-inpatient-sample-2010-2014/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology